Evidence map›Paper›PMID 25784056›Full record

ArticleScientific reports2015

CASP7 variants modify susceptibility to cervical cancer in Chinese women.

Ting-Yan Shi, Jing He, Meng-Yun Wang, Mei-Ling Zhu, Ke-Da Yu, Zhi-Ming Shao, Meng-Hong Sun, Xiaohua Wu, Xi Cheng, Qingyi Wei

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Oncotarget · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Relationship between hWAPL polymorphisms and cervical cancer susceptibility.International journal of clinical and experimental pathology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ting-Yan Shi1] Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China [2] Department of Obstetrics and Gynecology, Zhongshan Hospital Fudan University, Shanghai 200032, China.
Jing He1] Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China [2] State Key Laboratory of Oncology in South China, Department of Experimental Research, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510060, China.
Meng-Yun WangCancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Mei-Ling ZhuCancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Ke-Da YuDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Zhi-Ming ShaoDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Meng-Hong SunDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xiaohua WuDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Xi ChengDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Qingyi Wei1] Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China [2] Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA.
Fudan University Shanghai Cancer Center · CNDuke Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymorphisms in Caspase-7 (CASP7) may modulate the programmed cell death and thus contribute to cervical cancer risk. In this case-control study of 1,486 cervical cancer cases and 1,301 controls, we investigated associations between four potentially functional polymorphisms in CASP7 and cervical cancer risk and evaluated their locus-locus interaction effects on the risk. The genotype-phenotype correlation was performed by a generalized linear regression model. We found that the rs4353229 polymorphism was associated with cervical cancer risk (under a recessive model: crude OR = 1.20, 95% CI = 1.02-1.40). Compared with the TT genotype, the rs10787498GT genotype was associated with an increased cervical cancer risk (adjusted OR = 1.19, 95% CI = 1.00-1.41). Combination analysis showed that subjects with four putative risk genotypes had a 1.54-fold increased cancer risk, compared with those who carried three or less putative risk genotypes. We also observed significant locus-locus joint effects on the risk, which may be mediated by the polymorphisms regulating CASP7 mRNA expression. Subsequent multifactor dimensionality reduction and classification and regression tree analyses indicated that the CASP7 genotypes might have a locus-locus interaction effect that modulated cervical cancer risk. Out data suggest that CASP7 polymorphisms may interact to modify cervical cancer risk by a possible mechanism of regulating CASP7 mRNA expression.

Indexed as

Genetic Predisposition to DiseaseAllelesCase-Control StudiesCaspase 7ChinaDisease SusceptibilityFemaleGenetic Association StudiesGenetic LociGenotypeHumansLogistic ModelsOdds RatioPolymorphism, Single NucleotideRNA, MessengerUterine Cervical NeoplasmsCaspase 7RNA, Messenger

Identifiers

PMID25784056
PMCPMC4363885
OpenAlexW2047126238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.